Parasomnias

Disease-a-Month

Volumn 57, Issue 7, 2011, Pages 364-388

  Goldstein, Cathy A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DESMOPRESSIN; DONEPEZIL; DOSULEPIN; FLUNAZARINE; GABAPENTIN; IMIPRAMINE; LEVODOPA; MELATONIN; NABILONE; NEFAZODONE; NIFEDIPINE; OLANZAPINE; OXYBUTYNIN; PAROXETINE; PRAMIPEXOLE; PRAZOSIN; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAZODONE; TRIAZOLAM; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

AROUSAL; ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; COGNITIVE THERAPY; DESENSITIZATION; DISEASE CLASSIFICATION; DISSOCIATIVE DISORDER; EATING DISORDER; ELECTROENCEPHALOGRAM; ENURESIS; EXPLODING HEAD SYNDROME; FEAR; HALLUCINATION; HUMAN; HYPNOSIS; LOW DRUG DOSE; MENTAL DISEASE; MUSCLE TWITCH; NIGHTMARE; NONHUMAN; NONREM SLEEP; PARASOMNIA; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PONS; PSYCHOTHERAPY; REASSURANCE; REM SLEEP; SEXUAL AROUSAL DISORDER; SLEEP DISORDER; SLEEP RELATED EATING DISORDER; SLEEP WALKING; UNSPECIFIED SIDE EFFECT;

AROUSAL; DREAMS; HUMANS; PARALYSIS; PARASOMNIAS; SLEEP;

EID: 79960866190     PISSN: 00115029     EISSN: 15578194     Source Type: Journal    
DOI: 10.1016/j.disamonth.2011.04.007     Document Type: Article

References (72)

1. International classification of sleep disorders. Diagnostic and Coding Manual 2006, American Academy of Sleep Medicine, American: Academy of Sleep Medicine, Weschester, IL. 2nd ed.
2. Avidan A.Y., Kaplish N. The parasomnias: epidemiology, clinical features, and diagnostic approach. Clin Chest Med 2010, 31(2):353-370.
3. Ohayon M.M., Caulet M., Priest R.G. Violent behavior during sleep. J Clin Psychiatry 1997, 58(8):369-376.
4. Mahowald M.W., Scheck C.H. NREM parasomnias. Neurol Clin 2005, 23:1077-1106.
5. Hoque R., Chesson A.L. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: Fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 2009, 5(5):471-476.
6. Ohayon M.M., Guilleminault C., Priest R.G. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 1999, 60(4):268-276.
7. Petit D., Touchette E., Tremblay R.E., et al. Dyssomnias and parasomnias in early childhood. Pediatrics 2007, 119(5):1016-1025.
8. Schenck C.H., Pareja J.A., Patterson A.L., et al. Analysis of polysomnographic events surrounding 252 slow-wave sleep arousals in thirty-eight adults with injurious sleepwalking and sleep terrors. J Clin Neurophysiol 1998, 15(2):159-166.
9. Espa F., Ondze B., Deglise P., et al. Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophysiol 2000, 111:929-939.
10. Gaudreau H., Joncas S., Zadra A., et al. Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep 2000, 23(6):1-6.
11. Pilon M., Zadra A., Joncas S., et al. Hypersynchronous delta waves and somnambulism: brain topography and effect of sleep deprivation. Sleep 2006, 29(1):77-84.
12. Lecendreux M., Bassetti C., Dauvilliers Y., et al. HLA and genetic susceptibility to sleep walking. Mol Psychiatry 2002, 8:114-117.
13. Guilleminaut C., Moscovitch A., Yuen K., et al. Atypical sexual behavior during sleep. Psychosom Med 2002, 64:328-336.
14. Schenck C.H., Arnulf I., Mahowald M.W. Sleep and sex: what can go wrong?. Sleep 2007, 30(6):683-702.
15. Schenck C.H., Mahowald M.W. A polysomnographically documented case of adult somnambulism with long-distance automobile driving and frequent nocturnal violence: Parasomnia with continuing danger as a noninsane automatism?. Sleep 1995, 18(9):765-772.
16. Broughton R., Billings R., Cartright R., et al. Homicidal somnambulism: a case report. Sleep 1994, 17:253-264.
17. Attarian H. Treatment options for parasomnias. Neurol Clin 2010, 28(4):1089-1106.
18. Frank N.C., Spirito A., Stark L., et al. The use of scheduled awakenings to eliminate childhood sleepwalking. J Pediatr Psychol 1997, 22(3):345-353.
19. Tobin J. Treatment of somnambulism with anticipatory awakening. J Pediatr 1991, 122(3):426-427.
20. Harris M., Grunstein R.R. Treatments for somnambulism in adults: Assessing the evidence. Sleep Med Rev 2009, 13(4):295-297.
21. Jan J.E., Freeman R.D., Wasdell M.B., et al. A child with severe night terrors and sleep-walking responds to melatonin. Dev Med Child Neurol 2004, 49:787-789.
22. Bruni O., Ferri R., Miano S., et al. L-5-hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr 2004, 163(7):402-407.
23. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25(2):120-138.
24. Scheck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic REM sleep behaviour disorder. Neurology 1996, 46(2):388-393.
25. Schenck C.H., Bundlie S.R., Mahowald M.W. REM sleep behavior disorder delayed emergence of Parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the maximum and minimum tonic and/or phasic electromyographic abnormalities found in stage REM sleep. Sleep 2003, 26(Suppl):A316.
26. Iranzo A., Molinuevo J.L., Santamaria J., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurol 2006, 5(7):572-577.
27. Postuma R.B., Gagnon J.F., Vendette M., et al. Quantifying the risk of neurodegenerative disease in REM sleep behavior disorder. Neurology 2009, 72:1296-1300.
28. Iranzo A., Santamaria J., Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009, 13(6):385-401.
29. Scheck C.H., Hurwitz T.D., Mahowald M.W. REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993, 2:224-231.
30. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123(2):331-339.
31. Sforza E., Krieger J., Petiau C. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev 1997, 1:57-69.
32. Lu J., Sherman D., Devor M., et al. A putative flip flop switch for the control of REM sleep. Nature 2006, 441:589-594.
33. Winkelman J.W., James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004, 27(2):317-321.
34. Gagnon J.F., Postuma R.B., Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006, 67(5). 747-7.
35. Aurora R.N., Zak R.S., Magnati R.K., et al. Best practice guide for the treatment of REM sleep behavior disorder. J Clin Sleep Med 2010, 6(1):85-95.
36. Ohayon M.M., Zulley J., Guilleminault C., et al. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999, 52(6):1194-1200.
37. Munezawa T., Kaneita Y., Osaki Y., et al. Nightmare and sleep paralysis among Japanese adolescents: A nationwide representative survey. Sleep Med 2011, 12(1):56-64.
38. Leschziner G., Howard R.S., Williams A., et al. CP4 Isolated sleep paralysis as a presenting feature of obstructive sleep apnoea. J Neurol Neurosurg Psychiatry 2010, 81(11):e34.
39. Kotagal S. Parasomnias in childhood. Sleep Med Rev 2009, 13:157-168.
40. Levin R., Fireman G. Nightmare prevalence, nightmare distress, and self-reported psychological disturbance. Sleep 2002, 25(2):205-212.
41. Li S.X., Zhang B., Li A.M., et al. Prevalence and correlates of frequent nightmares: A community-based 2-phase study. Sleep 2010, 33(6):774-780.
42. Nielsen T., Paquette T., Solomonova E., et al. Changes in cardiac variability after REM sleep deprivation in recurrent nightmares. Sleep 2010, 33(1):113-122.
43. Lavie P. Sleep disturbances in the wake of traumatic events. N Engl J Med 2001, 345(25):1825-1832.
44. Davis J.L., Wright D.C. Randomized clinical trial for treatment of chronic nightmares in trauma-exposed adults. J Trauma Stress 2007, 20(2):123-133.
45. Taylor H.R., Freeman M.K., Cates M.E. Prazosin for treatment of nightmares related to posttraumatic stress disorder. Am J Health Syst Pharm 2008, 65(8):716-722.
46. Warner M.D., Dorn M.R., Peabody C.A. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry 2001, 34(4):128-131.
47. Gillin J.C., Smith-Vaniz A., Schnierow B., et al. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry 2001, 62(10):789-796.
48. Hamner M.B., Brodrick P.S., Labbate L.A. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry 2001, 13(3):141-146.
49. Aalbersberg C.F., Mulder J.M. Topiramate for the treatment of post traumatic stress disorder. A case study. Tijdschr Psychiatr 2006, 48(6):487-491. [in Dutch].
50. Jakovljevic M., Sagud M., Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD-a series of case reports. Acta Psychiatr Scand 2003, 107(5):394-396. [Discussion 396].
51. Fraser G.A. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 2009, 15(1):84-88.
52. Giesbrecht T., Lynn S.J., Lilienfeld S.O., et al. Cognitive processes in dissociation: an analysis of core theoretical assumptions. Psychol Bull 2008, 4(5):617-652.
53. Meltzer L.J., Johnson C., Crosette J., et al. Prevalence of diagnosed sleep disorders in pediatric primary care practices. Pediatrics 2010, 125(6). e1410-e8.
54. Byrd R.S., Weitzman M., Lanphear N.E., et al. Bed-wetting in US children: epidemiology and related behavior problems. Pediatrics 1996, 98(1):414-419.
55. Guilleminaut C., Hagen C., Catathrenia K.A. Parasomnia or uncommon feature of sleep disordered breathing. Sleep 2008, 31(1):132-139.
56. Vertugno R., Lugaresi E., Ferini-Strambi L., et al. (Nocturnal groaning): what is it?. Sleep 2008, 31(3):308-309.
57. Oldani A., Manconi M., Zuconi M., et al. Nocturnal groaning: just a sound or parasomnia?. J Sleep Res 2005, 14:305-310.
58. Chavravarty A. Exploding head syndrome: report of two new cases. Cephalgia 2008, 8(4):399-400.
59. Salih F., Klingebiel R., Zschenderlein R., et al. Acoustic sleep starts with sleep-onset insomnia related to a brainstem lesion. Neurology 2008, 70(20):1935-1937.
60. Palikh G.M., Vaughn B.V. Topiramate responsive exploding head syndrome. J Clin Sleep Med 2010, 6(4):382-383.
61. Ohayon M.M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000, 97:153-164.
62. Vertugno R., Vella A., Mascalchi M., et al. Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy. Sleep Med 2009, 10(10):1158-1160.
63. Winkleman J.W., Herzog D.B., Fava M. The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med 1999, 29:1461-1462.
64. Howell M.J., Schenck C.H. Treatment of nocturnal eating disorders. Curr Treat Options Neurol 2009, 11(5):333-339.
65. Provini F., Antelmi E., Vignatelli L., et al. Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord 2009, 24(6):871-877.
66. Molina S.M., Joshi K.G. A case of zaleplon-induced amnestic sleep-related eating disorder. J Clin Psychiatry 2010, 71(2):210-211.
67. Winkleman J.W. Efficacy and tolerability of open-label topirimate in the treatment of sleep related eating disorder: a retrospective case series. J Clin Psychiatry 2006, 67(11):1729-1734.
68. Provini F., Albani F., Vetrugno R., et al. A pilot, double-blind, placebo-controlled trial of low-dose pramipexole in sleep related eating disorder. Eur J Neurol 2005, 12(6):432-436.
69. Miyaoka T., Yasukawa R., Tsubouchi K., et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Clin Psychopharmacol 2003, 18(3):175-177.
70. Iranzo A., Santamaria J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 2005, 28(2):302-306.
71. Millman R.P., Kipp G.J., Carskadon M.A. Sleepwalking precipitated by treatment of sleep apnea with nasal CPAP. Chest 1991, 99:750-751.
72. Derry C.P., Harvey A.S., Walker M.C., et al. NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG analysis. Sleep 2009, 32(12):1637-1644.